Company intelligence / Profile preview
Cartherics
Melbourne/Notting Hill, Victoria, Australiacartherics.com ↗
- Ownership
- Private
- Employees
- ~45
- Development stage
- Other
01
Overview
Cartherics has demonstrated strong preclinical results with its lead product CTH‑401—an iPSC-derived CAR-NK cell targeting TAG‑72—showing effective killing of ovarian cancer cells in vitro and in animal models. The company plans to initiate its first clinical trial for this program in the near future. Its pipeline includes additional programs targeting other solid tumors and diseases such as endometriosis and Alzheimer’s disease. The company recently raised over AU$15 million to support these efforts.
- Therapeutic areas
- OncologyNeurologyWomen's Health
- Modalities
- Allogeneic (off-the-shelf) CAR-NK cellsAllogeneic CAR-T cellsAutologous CAR-T cellsExtracellular vesicles (EVs/exosomes)Gene-edited iPSC-derived immune cells (NK, T, macrophages)
- Industry
- Biotech
02
Drug pipeline
15 assets14 more assets in the full pipeline.
03
Partnerships
ToolGen (gene-editing tools)Ohio State University & TiCARos (collaborations on TF-CAR technology)various academic institutions for research partnerships
Beyond the preview
Go deeper on Cartherics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cartherics.